Human astrocytic bradykinin B(2) receptor modulates zymosan-induced cytokine expression in 1321N1 cells.
Bradykinin is an important modulator of the neurons and glial cells of the nervous system. Bradykinin secreted from neurons affects astrocytic functions such as neurovascular coupling and astrocytic cytokine production. In human astrocytes, however, the detailed mechanism of bradykinin-mediated modulation of astrocytic functions has not yet been fully elucidated. Here, we report the functional expression of the bradykinin B(2) receptor and its modulation of zymosan-induced cytokine expression in human astrocytoma 1321N1 cells. Bradykinin increased cytosolic [Ca(2+)] in a concentration-dependent manner, whereas [des-Arg(10)] kallidin (an agonist of the B(1) receptor) did not have this effect. Bradykinin also triggered intracellular InsP(3) production. Pretreating the cells with HOE140 (icatibant acetate, a B(2) receptor antagonist) inhibited the bradykinin-induced increase in cytosolic [Ca(2+)] and InsP(3) production. In contrast, [des-Arg(10)]HOE140 (a B(1) receptor antagonist) did not show any inhibitory effect. Bradykinin increased the zymosan-induced expression of TNF-alpha, and interleukin 1beta (IL-1beta) but did not affect the expression of interleukin 6 (IL-6) or interleukin 10 (IL-10). Interestingly, a cyclooxygenase-2 specific inhibitor blocked the bradykinin-induced effect. In contrast to the result in human glioma cells, bradykinin inhibits the zymosan-induced expression of TNF-alpha and IL-1beta in rat astrocytes, which shows a species-dependent manner. These data suggest that bradykinin B(2) receptors are expressed in human astrocytoma cells and that they modulate the expression pattern of inflammatory cytokines.
Department of Physiology and Dental Research Institute, Seoul National University School of Dentistry, Seoul, Republic of Korea.
Donghoon
D
Kim
Suk-Hee
SH
Cho
Jong-So
JS
Kim
Su-Hyun
SH
Jo
Sung Joong
SJ
Lee
Kyong-Tai
KT
Kim
Se-Young
SY
Choi
D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000378:metabolism*; D001920:Bradykinin / Q000031:analogs & derivatives / Q000378:metabolism; D020013:Calcium Signaling / Q000502:physiology; D045744:Cell Line, Tumor; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000503:physiopathology; D053583:Interleukin-1beta / Q000276:immunology; D051381:Rats; D043782:Receptor, Bradykinin B2 / Q000378:metabolism*; D013045:Species Specificity; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D015054:Zymosan / Q000276:immunology / Q000494:pharmacology
D016207:Cytokines; D053583:Interleukin-1beta; D043782:Receptor, Bradykinin B2; D051195:Toll-Like Receptor 2; D014409:Tumor Necrosis Factor-alpha; D015054:Zymosan; D001920:Bradykinin